The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.

Saved in:
Bibliographic Details
Title: The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.
Authors: Copin R; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Baum A; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Wloga E; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Pascal KE; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Giordano S; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Fulton BO; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Zhou A; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Negron N; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Lanza K; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Chan N; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Coppola A; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Chiu J; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Ni M; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Wei Y; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Atwal GS; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Hernandez AR; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Saotome K; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Zhou Y; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Franklin MC; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Hooper AT; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., McCarthy S; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Hamon S; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Hamilton JD; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Staples HM; Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX 78245, USA., Alfson K; Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX 78245, USA., Carrion R Jr; Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX 78245, USA., Ali S; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Norton T; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Somersan-Karakaya S; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Sivapalasingam S; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Herman GA; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Weinreich DM; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Lipsich L; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Stahl N; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Murphy AJ; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Yancopoulos GD; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Kyratsous CA; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA. Electronic address: christos.kyratsous@regeneron.com.
Source: Cell [Cell] 2021 Jul 22; Vol. 184 (15), pp. 3949-3961.e11. Date of Electronic Publication: 2021 Jun 05.
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4172 (Electronic) Linking ISSN: 00928674 NLM ISO Abbreviation: Cell Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1097-4172
DOI:10.1016/j.cell.2021.06.002